Bedard PL - Search Results

1

Personalized medicine for metastatic breast cancer.

Chen TW, Bedard PL. Chen TW, et al. Among authors: bedard pl. Curr Opin Oncol. 2013 Nov;25(6):615-24. doi: 10.1097/CCO.0000000000000015. Curr Opin Oncol. 2013. PMID: 24097103 Review.

2

Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?

Bedard PL, Freedman OC, Howell A, Clemons M. Bedard PL, et al. Breast Cancer Res Treat. 2008 Apr;108(3):307-17. doi: 10.1007/s10549-007-9606-8. Epub 2007 May 22. Breast Cancer Res Treat. 2008. PMID: 18351454 Review.

3

Beyond trastuzumab: overcoming resistance to targeted HER-2 therapy in breast cancer.

Bedard PL, de Azambuja E, Cardoso F. Bedard PL, et al. Curr Cancer Drug Targets. 2009 Mar;9(2):148-62. doi: 10.2174/156800909787581024. Curr Cancer Drug Targets. 2009. PMID: 19275756 Review.

4

Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer.

Bedard PL, Piccart-Gebhart MJ. Bedard PL, et al. Curr Opin Oncol. 2009 Nov;21(6):491-8. doi: 10.1097/CCO.0b013e32832fc8b0. Curr Opin Oncol. 2009. PMID: 19593135 Review.

5

Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?

Bedard PL, Cardoso F. Bedard PL, et al. Nat Rev Clin Oncol. 2011 May;8(5):272-9. doi: 10.1038/nrclinonc.2011.19. Epub 2011 Mar 1. Nat Rev Clin Oncol. 2011. PMID: 21364525 Review.

6

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

Bedard PL, Singhal SK, Ignatiadis M, Bradbury I, Haibe-Kains B, Desmedt C, Loi S, Evans DB, Michiels S, Dixon JM, Miller WR, Piccart MJ, Sotiriou C. Bedard PL, et al. Endocr Relat Cancer. 2011 Nov 14;18(6):721-30. doi: 10.1530/ERC-11-0180. Print 2011 Dec. Endocr Relat Cancer. 2011. PMID: 21984694

7

Luminal-B breast cancer and novel therapeutic targets.

Tran B, Bedard PL. Tran B, et al. Among authors: bedard pl. Breast Cancer Res. 2011;13(6):221. doi: 10.1186/bcr2904. Epub 2011 Nov 30. Breast Cancer Res. 2011. PMID: 22217398 Free PMC article. Review.

8

Management of small HER2 overexpressing tumours.

Templeton A, Ocaña A, Seruga B, Vera-Badillo F, Carlsson L, Bedard P, Amir E. Templeton A, et al. Breast Cancer Res Treat. 2012 Nov;136(1):289-93. doi: 10.1007/s10549-012-2236-9. Epub 2012 Sep 6. Breast Cancer Res Treat. 2012. PMID: 22956007

9

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.

Miller FA, Hayeems RZ, Bytautas JP, Bedard PL, Ernst S, Hirte H, Hotte S, Oza A, Razak A, Welch S, Winquist E, Dancey J, Siu LL. Miller FA, et al. Among authors: bedard pl. Eur J Hum Genet. 2014 Mar;22(3):391-5. doi: 10.1038/ejhg.2013.158. Epub 2013 Jul 17. Eur J Hum Genet. 2014. PMID: 23860039 Free PMC article.

10

Complete Response of Metastatic Androgen Receptor-Positive Breast Cancer to Bicalutamide: Case Report and Review of the Literature.

Arce-Salinas C, Riesco-Martinez MC, Hanna W, Bedard P, Warner E. Arce-Salinas C, et al. J Clin Oncol. 2016 Feb 1;34(4):e21-4. doi: 10.1200/JCO.2013.49.8899. Epub 2014 Jun 2. J Clin Oncol. 2016. PMID: 24888812 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters